AXQ Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $669K | Buy |
+12,175
| New | +$669K | 0.22% | 145 |
|
|
2024
Q4 | – | Sell |
-23,022
| Closed | -$1.62M | – | 444 |
|
|
2024
Q3 | $1.62M | Buy |
23,022
+2,323
| +11% | +$163K | 0.49% | 37 |
|
|
2024
Q2 | $1.7M | Buy |
20,699
+5,399
| +35% | +$445K | 0.4% | 73 |
|
|
2024
Q1 | $1.34M | Buy |
15,300
+11,100
| +264% | +$969K | 0.32% | 91 |
|
|
2023
Q4 | $405K | Sell |
4,200
-200
| -5% | -$19.3K | 0.11% | 310 |
|
|
2023
Q3 | $389K | Sell |
4,400
-1,100
| -20% | -$97.3K | 0.14% | 258 |
|
|
2023
Q2 | $477K | Buy |
+5,500
| New | +$477K | 0.59% | 41 |
|